Skip to Content


Main Content

HLA-mismatches in the setting of post-transplant cyclophosphamide and lymphomas: matched unrelated vs. haploidentical donors joint analysis with EBMT

Study #: IB20-04

Study Status: Published


2021, ASH (Oral)
2022, Tandem (Oral)
2022, EBMT (Oral)

Haploidentical versus matched unrelated donor transplants using post-transplantation cyclophosphamide for lymphomas.


Mussetti A, Kanate AS, Wang T, He M, Hamadani M, Finel H Sr, Boumendil A Sr, Glass B, Castagna L, Dominietto A, McGuirk J, Blaise D, Gülbas Z, Diez-Martin J, Marsh SGE, Paczesny S, Gadalla SM, Dreger P, Zhang MJ, Spellman SR, Lee SJ, Bolon YT, Sureda A.

Transplantation and Cellular Therapy. 2023, Mar 01: 29(3): 29(3):184.e1-184.e9. doi: 10.1016/j.jtct.2022.11.028. Epub 2022, Dec 25. PMCID:PMC10316698.


PMID: 36577482